Literature DB >> 30225825

The prevalence of underweight and overweight/obesity and its correlates among adults in Laos: a cross-sectional national population-based survey, 2013.

Supa Pengpid1,2, Manithong Vonglokham3, Sengchanh Kounnavong3, Vanphanom Sychareun4, Karl Peltzer5,6.   

Abstract

PURPOSE: The study aimed to assess the prevalence of underweight and overweight or obesity and their sociodemographic, lifestyle, and health factors in a national adult population in Lao People's Democratic Republic (PDR) (Laos).
METHODS: A national cross-sectional study based on a stratified cluster random sampling was conducted in 2013. The total sample included 2531 individuals 18-64 years, (females = 59.3%; mean age 38.7 years, SD = 12.8) from Laos. Questionnaire interview, blood pressure and anthropometric measurements, and biochemistry tests were conducted. Multinomial logistic regression was utilized to determine the association between sociodemographic, lifestyle and health status factors, and underweight and overweight or obesity relative to normal weight.
RESULTS: Using Asian criteria for body mass index (BMI) classification, 9.7% of the population was underweight (BMI < 18.5, kg/m2), 47.5% had normal weight (BMI 18.5-22.9 kg/m2), 17.5% overweight (23.0-24.9 kg/m2), 19.6% class I obesity (BMI 25.0-29.9 kg/m2), and 5.6% class II obesity (BMI ≥ 30.0 kg/m2) (or 42.8% overweight, class I or class II obesity). In adjusted multinomial logistic regression, female sex (adjusted relative risk ratio-ARRR 0.67, confidence interval-CI 0.45, 0.99), current tobacco use (ARRR 1.57, CI 1.02, 2.41), and having no hypertension (ARRR 0.50, CI 0.26, 0.97) were associated with underweight, and middle and older age (ARRR 1.79, CI 1.41, 2.25), being Lao-Tai (ARRR 1.37, CI 1.06, 1.76), urban residence (ARRR 1.62, CI 1.20, 2.17), having meals outside home (ARRR 1.36, CI 1.04, 1.77), no current tobacco use (ARRR 0.57, CI 0.34, 0.59), low physical activity (ARRR 1.39, CI 1.01, 1.92), having hypertension (ARRR 2.52, CI 1.94, 3.26), and dyslipidaemia (ARRR 1.56, CI 1.21, 2.00) were associated with overweight or obesity.
CONCLUSION: A dual burden of both adult underweight and overweight or obesity was found in Laos. Sociodemographic, lifestyle, and health status risk factors were identified for underweight and overweight or obesity, which can help in guiding public health programmes to address both these conditions. LEVEL OF EVIDENCE: Level V, descriptive cross-sectional survey.

Entities:  

Keywords:  Adults; Dietary behaviour; Laos; Obesity; Overweight; Physical activity; Underweight

Mesh:

Year:  2018        PMID: 30225825     DOI: 10.1007/s40519-018-0571-5

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  34 in total

1.  Global changes in diet and activity patterns as drivers of the nutrition transition.

Authors:  Barry M Popkin
Journal:  Nestle Nutr Workshop Ser Pediatr Program       Date:  2009

2.  Predictors of BMI Vary along the BMI Range of German Adults - Results of the German National Nutrition Survey II.

Authors:  Kilson Moon; Carolin Krems; Thorsten Heuer; Alexander Roth; Ingrid Hoffmann
Journal:  Obes Facts       Date:  2017-02-21       Impact factor: 3.942

3.  Undernutrition among adults in India: the significance of individual-level and contextual factors impacting on the likelihood of underweight across sub-populations.

Authors:  Md Zakaria Siddiqui; Ronald Donato
Journal:  Public Health Nutr       Date:  2016-08-12       Impact factor: 4.022

Review 4.  The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.

Authors:  Massimo Leggio; Mario Lombardi; Elisa Caldarone; Paolo Severi; Stefania D'Emidio; Massimo Armeni; Veronica Bravi; Maria Grazia Bendini; Andrea Mazza
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

5.  Prevalence and trends of obesity and association with socioeconomic status in Thai adults: National Health Examination Surveys, 1991-2009.

Authors:  Wichai Aekplakorn; Rungkarn Inthawong; Pattapong Kessomboon; Rassamee Sangthong; Suwat Chariyalertsak; Panwadee Putwatana; Surasak Taneepanichskul
Journal:  J Obes       Date:  2014-03-17

6.  Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences.

Authors:  Marco D DiBonaventura; Henrik Meincke; Agathe Le Lay; Janine Fournier; Erik Bakker; Allison Ehrenreich
Journal:  Diabetes Metab Syndr Obes       Date:  2017-12-22       Impact factor: 3.168

Review 7.  The medical risks of obesity.

Authors:  Xavier Pi-Sunyer
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

8.  Prevalence and determinants of adult under-nutrition in Botswana.

Authors:  Gobopamang Letamo; Kannan Navaneetham
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

9.  Smoking and body weight: evidence from China health and nutrition survey.

Authors:  Qing Wang
Journal:  BMC Public Health       Date:  2015-12-14       Impact factor: 3.295

10.  The double burden of malnutrition in Indonesia: Social determinants and geographical variations.

Authors:  Wulung Hanandita; Gindo Tampubolon
Journal:  SSM Popul Health       Date:  2015-11-18
View more
  3 in total

1.  Are dietary intake and nutritional status influenced by gender? The pattern of dietary intake in Lao PDR: a developing country.

Authors:  Kethmany Ratsavong; Tessa van Elsacker; Daovieng Doungvichit; Latsamy Siengsounthone; Sengchanh Kounnavong; Dirk Essink
Journal:  Nutr J       Date:  2020-04-11       Impact factor: 3.271

2.  Underweight and overweight/obesity among adults in Afghanistan: prevalence and correlates from a national survey in 2018.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  J Health Popul Nutr       Date:  2021-06-06       Impact factor: 2.000

3.  The prevalence and associated factors of underweight and overweight/obesity among adults in Kenya: evidence from a national cross-sectional community survey.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Pan Afr Med J       Date:  2020-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.